Status:
NOT_YET_RECRUITING
Validation of Heart Failure Risk Scores MAGGIC, GWTG-HF, and SHFM in Egyptian Patients
Lead Sponsor:
Assiut University
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Heart failure (HF) affects over 64 million people worldwide and carries high morbidity, frequent hospitalizations, and major economic burden. Accurate risk stratification is essential to guide therapy...
Detailed Description
Heart failure (HF) is a major global public health problem, affecting more than 64 million people worldwide \[1\]. It is associated with high morbidity, frequent hospitalizations, poor quality of life...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥18 years.
- Clinical HF diagnosis (per ESC/ACC/AHA criteria).
- Available baseline data to compute ≥1 of the three scores within 24h of index assessment (admission or clinic baseline).
- For longitudinal endpoints: reachable for follow-up.
- Exclusion criteria:
- Cardiogenic shock requiring immediate MCS at presentation (analyzed separately).
- Isolated right HF from primary pulmonary disease without LV involvement (for main analysis
Exclusion
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07194889
Start Date
October 1 2025
End Date
October 1 2027
Last Update
October 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.